The systemic AAV delivery of SaCas9 components is further reported to restore functional dystrophin expression in the heart of humanized DMD mice with an exon 52-deleted human dystrophin gene (hDMDΔ52/mdx) [40]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.